Pharma IT Insights
Bridging the Biopharma Talent Gap:
Solving Scale-Up Challenges in Biopharmaceutical Manufacturing
By Sri Ramkumar Vijayan
July 24, 2025
Pharma IT Insights
Bridging the Biopharma Talent Gap:
Solving Scale-Up Challenges in Biopharmaceutical Manufacturing
By Sri Ramkumar Vijayan
July 24, 2025
As demand surges for biologics and advanced therapies, biopharmaceutical manufacturers are under growing pressure to scale operations quickly, safely, and in compliance with global regulations. Yet for many companies, the biggest barrier to successful scale-up isn't infrastructure or equipment — it's people.
The challenge of scaling biopharmaceutical manufacturing is no longer just a technical one. A persistent biopharma talent gap is making it harder to transfer processes, validate systems, and ensure product quality at every stage of growth.
In Denmark and across the Nordics — where biomanufacturing is growing rapidly — the strain on available talent is becoming a critical limiting factor.
The Human Factor in Scale-Up
Scaling from clinical to commercial production involves much more than simply increasing batch size. It requires orchestrating cross-functional efforts across process development, validation, QA, regulatory, and tech transfer teams. These efforts must align with evolving regulatory standards from authorities such as the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA), including revised guidance like Annex 1 (focused on contamination control and aseptic processing) and frameworks like ASTM E2500 and GAMP 5 for validation and digital integration.
But many organizations lack the specialized expertise to manage these transitions smoothly. The 2023 Global Biopharma Resilience Index found that workforce capability is one of the top constraints in manufacturing growth (Cytiva).
When essential roles go unfilled — particularly those that blend technical and regulatory fluency — critical projects stall, and the risk of non-compliance increases.
Why the Talent Gap Matters
Without the right capabilities in place, companies may experience:
- Delays in tech transfer and scale-up
- Gaps in validation protocols and audit readiness
- Burnout among internal staff stretched too thin
- Lost market opportunities and increased regulatory risk
This is especially pressing in Denmark, a European biomanufacturing hub where growing demand for specialized biologics talent (including upstream/downstream scientists, QA professionals, and validation engineers) has outpaced supply.
Three-Tiered Solution: Training, Upskilling, and Expert Support
To navigate the complexity of scale-up amid talent shortages, biopharma manufacturers are increasingly adopting a three-tiered approach:
- Build internal capability through structured training
- Accelerate team development via embedded coaching
- Bridge immediate gaps with specialized external support
1. Long-Term Solution: Build Internal Capability Through Training
Structured training programs help build in-house expertise in key areas, including:
- GMP requirements and documentation best practices
- Risk-based validation approaches aligned with ICH Q8–Q11 and ASTM E2500
- Process qualification protocols (IQ/OQ/PQ)
- Digital tools for compliance, including eQMS and LIMS
Training doesn’t just build knowledge — it improves retention, strengthens quality culture, and reduces reliance on external consultants over time.
2. Medium-Term Solution: Upskill Teams Through Embedded Coaching or Secondments
Some companies benefit from a more hands-on, project-integrated approach to growing internal capability. That’s where embedded consultants or coaching-based secondments can make a difference:
- Experts work alongside your team during active projects
- Knowledge transfer happens in real time, tailored to your systems
- Staff gain confidence and practical experience under expert guidance
- Ideal for tech transfer, validation, regulatory prep, or QA scale-up
This model blends execution with learning — helping teams grow while delivering on immediate project needs.
3. Short-Term Solution: Partner with Specialized External Experts
While internal capability grows, companies still need to keep timelines on track. Partnering with external experts helps fill urgent gaps by:
- Moving lab-scale processes into GMP manufacturing
- Preparing and executing tech transfer and validation packages
- Strengthening QA oversight and preparing for audits
- Integrating digital tools like electronic batch records and data systems
This support ensures momentum — even when internal bandwidth is limited — and helps reduce compliance risk during high-stakes transitions.
How Our Team Supports Scale-Up Success
We bring deep, hands-on expertise to help biopharma teams meet aggressive timelines while maintaining GMP compliance. Whether you’re scaling up in-house or through a CMO/CDMO, our consultants are equipped to step in quickly and deliver results.
We offer specialized support in:
- Upstream Processing: Seed train strategies, bench-to-pilot scale bioreactors (CHO, coli, Pichia pastoris), CPP management, and PAT tools
- Downstream Processing: TFF, chromatography (affinity, IEX, SEC), viral clearance steps, method development, and buffer optimization
- Analytical Method Development: HPLC, ELISA, CE, UV/VIS, DLS, MS, DSC, and cell-based assays, in accordance with ICH Q2 (R1)
- Technology Transfer: Authoring of tech transfer packages, alignment on CQAs and CPPs, troubleshooting during scale-up, and process validation
- Validation and Documentation: IQ/OQ/PQ protocols, SOPs, risk assessments (QRM), and batch records — aligned with GAMP 5 and ASTM E2500
- Regulatory & QA Support: Audit readiness, deviation and change control, regulatory submissions (FDA/EMA), and support for implementing digital QA tools like eQMS and LIMS
Our team is available for on-site or remote roles across Denmark and the Nordics, and we tailor our support to fit your internal workflows and regulatory landscape.
Closing Thoughts: Scale with Confidence
The biopharma talent gap doesn’t have to stop your scale-up plans. By combining training, embedded coaching, and flexible expert support, manufacturers can build strong internal teams, maintain project momentum, and scale up without compromising on quality or compliance.
📩 Need support with scale-up, validation, or tech transfer? Let’s connect. Our consultants are ready to help your team bridge the gap — and scale confidently. Contact us today to start the conversation.
About the author
Sri Ramkumar Vijayan is Manufacturing Consultant at Pharma IT and holds over 10 years of experience as a Bioprocess Scientist, with research expertise in upstream and downstream processes. Sri specializes in the fermentation and purification of biomolecules, particularly proteins and lipopeptides, from cell cultures, with strong proficiency in analytical techniques.
